Correlation Between Entero Therapeutics, and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Entero Therapeutics, and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and Amylyx Pharmaceuticals.
Diversification Opportunities for Entero Therapeutics, and Amylyx Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Entero and Amylyx is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Entero Therapeutics, and Amylyx Pharmaceuticals
Given the investment horizon of 90 days Entero Therapeutics, is expected to under-perform the Amylyx Pharmaceuticals. In addition to that, Entero Therapeutics, is 1.52 times more volatile than Amylyx Pharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 1,422 in Amylyx Pharmaceuticals on September 2, 2024 and sell it today you would lose (868.00) from holding Amylyx Pharmaceuticals or give up 61.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Entero Therapeutics, vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Entero Therapeutics, |
| Amylyx Pharmaceuticals |
Entero Therapeutics, and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entero Therapeutics, and Amylyx Pharmaceuticals
The main advantage of trading using opposite Entero Therapeutics, and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Entero Therapeutics, vs. Tff Pharmaceuticals | Entero Therapeutics, vs. Eliem Therapeutics | Entero Therapeutics, vs. Inhibrx | Entero Therapeutics, vs. Enliven Therapeutics |
| Amylyx Pharmaceuticals vs. Agilent Technologies | Amylyx Pharmaceuticals vs. Equillium | Amylyx Pharmaceuticals vs. 23Andme Holding Co | Amylyx Pharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |